Event | 29 May 2024

Navigating the BIOSECURE Act

Our Global Life Sciences and Health Care team and Global Regulatory Practice are here to help address questions you may have with government contracts, trade, regulatory, and commercial implications of the BIOSECURE proposals. We can advise you on the best practices to get ahead of the curve and assess and mitigate risk.

Featured events

BIOSECURE Act: How companies can begin preparing

Hogan Lovells' APAC Life Sciences and Health Care Webinar Series: Spotlight on the...

Our speakers

Tim Bergreen

Senior Counsel
Washington, D.C.

Ajay Kuntamukkala

Office Managing Partner
Washington, D.C.

Joy E. Sturm

Partner
Washington, D.C.

Michael N. Druckman

Partner
Washington, D.C.

Other resources

The BIOSECURE Act aims to restrict funding and genetic data use by foreign adversary ...

U.S. BIOSECURE Act: Key considerations for global cell, tissue, and gene therapy...